The California-Israel Collaborations in Research Program brings together scientists from UC Davis and Israel to boost science ...

The post Pancreatic Cancer Vaccine Shows Potential in Early Trial appeared first on Reason.com.

Fewer precancerous lesions are being found in young women undergoing cervical cancer screenings thanks to the human ...

Because almost all cases of cervical cancer can be traced to HPV, some countries think the vaccine will help them eliminate ...

From 2008 to 2022, rates for precancerous lesions decreased about 80 percent among 20- to 24-year-old women who were screened ...

The study shows an almost 80% drop in rates of cervical precancers among women ages 20-24 from 2008 to 2022, correlating to vaccine uptake. Simultaneously, an mRNA pancreatic cancer vaccine is showing ...

Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...

A new study from Memorial Sloan Kettering Cancer Center shows good results for patients with pancreatic cancer. They used a ...

A Yale study achieved 100% remission in nine kidney cancer patients using a personalized vaccine, eliminating tumors for ...

An early-phase trial found that a personalized vaccine targeted and destroyed cancer cells in nine patients with advanced kidney cancer, effectively wiping out the disease and keeping it at bay ...